UROREC

This brand name is authorized in Australia, Austria, Croatia, Cyprus, Estonia, Finland, France, Germany, Ireland, Italy, Lithuania, Poland, Romania, Spain, Tunisia, Turkey.

Active ingredients

The drug UROREC contains one active pharmaceutical ingredient (API):

1	Silodosin UNII CUZ39LUY82 - SILODOSIN
	Silodosin is highly selective for α1A-adrenoreceptors that are primarily located in the human prostate, bladder base, bladder neck, prostatic capsule and prostatic urethra. Blockade of these α1A-adrenoreceptors causes smooth muscle in these tissues to relax, thus decreasing bladder outlet resistance, without affecting detrusor smooth muscle contractility.
	Read more about Silodosin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
UROREC Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04CA04	Silodosin	G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	12077P, 12079R
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	06476198, 06476206, 06476229, 06476235, 08806027, 08806033, 09284275, 09284281, 09493441, 09674409, 09715568, 13589170, 15994644
EE	Ravimiamet	1459548, 1459559, 1459560, 1459571, 1459582, 1459593, 1459605, 1459616, 1459627, 1459638, 1459649, 1459650, 1459661, 1459672
ES	Centro de información online de medicamentos de la AEMPS	09608004, 09608004IP, 09608011, 09608011IP, 09608011IP1, 09608011IP2, 09608011IP3
FI	Lääkealan turvallisuus- ja kehittämiskeskus	124714, 474180, 533694
FR	Base de données publique des médicaments	65024515, 69141416
IE	Health Products Regulatory Authority	13220, 47500, 47512, 47513, 47540, 47541
IT	Agenzia del Farmaco	039789045, 039789110
LT	Valstybinė vaistų kontrolės tarnyba	1053026, 1053027, 1053028, 1053029, 1053030, 1053031, 1053032, 1053035, 1053036, 1053037, 1053038, 1053039, 1053040, 1053041
PL	Rejestru Produktów Leczniczych	100074739, 100292710
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W56136001, W56136002, W56136003, W56136004, W56136005, W56136006, W56136007, W56137001, W56137002, W56137003, W56137004, W56137005, W56137006, W56137007
TN	Direction de la Pharmacie et du Médicament	14223011, 14223012
TR	İlaç ve Tıbbi Cihaz Kurumu	8699559150087, 8699559150094